FindTrial
Sign In

Pattern of distant spread of thyroid cancer

Pattern of Distant metastasis in Differentiated thyroid carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/04/051298
Enrollment
100
Registered
2023-04-05
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C73- Malignant neoplasm of thyroid gland

Interventions

None listed

Sponsors

Amrita Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with papillary, follicular, hurthle cell carcinoma with whole body iodine scintigraphy showing distant metastasis

Exclusion criteria

Exclusion criteria: 1.Patients with primary tumor elsewhere 2. Patients with anaplastic thyroid carcinoma 3.Patients with medullary thyroid carcinoma 4.Patients with lymphoma 5.Unclear diagnostic about primary or metastatic tumor

Design outcomes

Primary

MeasureTime frame
To study the pattern of distant metastasis in patients with differentiated thyroid carcinomaTimepoint: 8 weeks—

Secondary

MeasureTime frame
To determine 1) Prognostic factors of clinical outcome 2) 5 year cancer specific survival rate 3) Treatment modalities offeredTimepoint: Patients will be assessed from the time of diagnosis of distant metastasis and at 5 years from the diagnosis of distant metastasis—

Countries

India

Contacts

Public ContactPradeep Jacob

Amrita Institute of Medical Sciences

peejaydoc@gmail.com9496334636

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026